Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

Area of Science:

• Biochemistry
• Immunology
• Medical Diagnostics

Background:

• Pleural effusion diagnosis can be challenging.
• Adenosine deaminase (ADA) is a biomarker for tuberculosis (TB), but lacks specificity.
• Dipeptidyl peptidase-IV (DPP-IV) and soluble CD26 (sCD26) are related enzymes with potential diagnostic roles.

Purpose of the Study:

• To evaluate the diagnostic utility of ADA, DPP-IV, and sCD26 in pleural effusions.
• To determine if DPP-IV improves the specificity of ADA for pulmonary tuberculosis diagnosis.
• To investigate the potential of these markers in differentiating malignant from benign pleural effusions.

Main Methods:

• Measurement of ADA and DPP-IV enzymatic activity and sCD26 concentration in 150 pleural effusion samples.
• Correlation analysis with cellular and biochemical parameters.
• Immunoblotting to detect specific protein patterns.

Main Results:

• DPP-IV improved the specificity of the ADA test for pulmonary tuberculosis, reducing false positives in non-tuberculous effusions.
• Some patients with malignant pleural effusion tested positive for sCD26 or DPP-IV, but positive results were also observed in benign effusions.
• A DPP-IV-associated pattern in pleural effusion correlated with leukocyte presence and a 180 kDa band detected by immunoblotting.

Conclusions:

• DPP-IV activity can enhance the diagnostic specificity of ADA for tuberculosis.
• DPP-IV and sCD26 show some association with malignant pleural effusion but require further investigation for definitive diagnostic value.
• The observed DPP-IV pattern linked to leukocytes suggests a potential role in understanding pleural effusion pathogenesis and diagnosis.